MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $400
Analyst Ratings
AMGN
Oct 21
AI-curated analysis for informational purposes only — not investment advice.
Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $400
Read the full story at benzinga.com →